NuVasive, Inc. NUVA recently announced favorable results from the study — Single-position prone lateral approach: cadaveric feasibility — and early clinical experience, which was published in The ...
SAN DIEGO, April 2, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
SAN DIEGO, Feb. 13, 2020 /PRNewswire/ --NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
The XLIF Decade(TM) Plate System is designed to provide a simple, yet comprehensive, stabilization solution with four points of fixation for enhanced biomechanical rigidity and load sharing. Designed ...
Medtronic ($MDT) may be at risk of losing big in a patent battle with one company, but the Minnesota device giant is on the winning side of a dustup with rival ...
NuVasive (NUVA) is $1.5 billion medical device company specializing in products for the surgical treatment of spine disorders. NUVA's main platform, Maximum Access Surgery (MAS), allows the surgeon to ...
NuVasive ($NUVA) has agreed to shell out $45 million to Medtronic ($MDT) to settle an old patent dispute over spinal implant technology that dates back to 2008. San ...
SAN DIEGO, CA--(Marketwired - Jun 12, 2013) - NuVasive, Inc. (NASDAQ: NUVA) a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, ...
NuVasive had to raise its litigation royalty expense estimate for the year after a U.S. District Court set royalty rates for the company’s CoRoent XL implants at 13.75 percent and MaXcess retractors ...
Tina Jacobsen, Director of Investor Relations, NuVasive, Inc. (NUVA), announced that the company will focus next on international growth at the 34th Annual Canaccord Genuity Growth Conference at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback